首页 › 基金 › Deep Track Capital, LP › IONS
Deep Track Capital, LP 对 IONS 的持仓历史
IONIS PHARMACEUTICALS INC · 医疗保健
Deep Track Capital, LP 在 Q2 2026 的 13F 申报中披露持有 IONS(IONIS PHARMACEUTICALS INC)2,200,000 股,市值约 US$174.4M,约占其申报组合的 2.60%,在其申报持仓中市值排名第 15 位。 Deep Track Capital, LP 最近 12 个申报季度中有 12 个季度披露了 IONS 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Deep Track Capital, LP 对 IONS 的持仓演变
Deep Track Capital, LP 于 Q3 2023 首次披露 IONS 持仓:2,834,069 股(约 US$128.6M)。 该持仓在 Q3 2025 达到峰值 3,808,144 股,市值约 US$249.1M。 在 12 次申报中,Deep Track Capital, LP 7 次增持、4 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 2,200,000 股、市值约 US$174.4M,环比增持 250,000 股。。 持仓曾出现大幅变动:Q4 2023 减持约 56% (随后一个季度股价下跌 14%)、Q1 2025 增持约 136% (随后一个季度股价上涨 31%)、Q4 2025 减持约 55% (随后一个季度股价下跌 5%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.83M | $128.55M | 新进 |
| Q4 2023 | 1.25M | $63.19M | 减持 |
| Q1 2024 | 1.37M | $59.54M | 增持 |
| Q2 2024 | 2.00M | $95.32M | 增持 |
| Q3 2024 | 2.20M | $88.13M | 增持 |
| Q4 2024 | 1.93M | $67.61M | 减持 |
| Q1 2025 | 4.56M | $137.70M | 增持 |
| Q2 2025 | 4.89M | $193.26M | 增持 |
| Q3 2025 | 3.81M | $249.13M | 减持 |
| Q4 2025 | 1.70M | $134.49M | 减持 |
| Q1 2026 | 1.95M | $146.43M | 增持 |
| Q2 2026 | 2.20M | $174.44M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IONS 与 13F 数据
IONS(IONIS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 IONS,申报仓位最大的包括:双西格玛投资 (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IONS 的基金
- 双西格玛投资 6.25M 股 · $495.75M · Q2 2026
- TWO SIGMA ADVISERS, LP 3.05M 股 · $241.45M · Q4 2025
- Tweedy, Browne Co LLC 2.28M 股 · $180.81M · Q2 2026
- BAKER BROS. ADVISORS LP 2.05M 股 · $162.36M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 94.68M 股 · $147.77M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 60.00M 股 · $93.10M · Q2 2026
- Bellevue Group AG 972.26K 股 · $77.09M · Q2 2026
- GROUPAMA ASSET MANAGMENT 937.08K 股 · $75.20M · Q2 2026
- Davern Capital Partners, LP 798.71K 股 · $63.33M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 787.26K 股 · $62.42M · Q2 2026
- Eversept Partners, LP 664.68K 股 · $52.70M · Q2 2026
更多关于 Deep Track Capital, LP
常见问题
How long has Deep Track Capital, LP held IONS?
Deep Track Capital, LP has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Deep Track Capital, LP's current position in IONS?
As of Q2 2026, Deep Track Capital, LP holds 2.20M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $174.44M, representing 2.60% of its reported portfolio and ranking #15.
Has Deep Track Capital, LP been buying or selling IONS?
In the latest 13F filing (Q2 2026), Deep Track Capital, LP increased its position in IONS. The position peaked in Q3 2025 at 3.81M shares.
Which other funds hold IONS?
Other major institutional holders of IONS include 双西格玛投资, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.